NYSE:EVH Evolent Health (EVH) Stock Price, News & Analysis $3.94 +0.11 (+2.73%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$3.94 0.00 (0.00%) As of 05/22/2026 04:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Evolent Health Stock (NYSE:EVH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Evolent Health alerts:Sign Up Key Stats Today's Range$3.80▼$3.9950-Day Range$2.17▼$4.2952-Week Range$2.10▼$12.06Volume2.20 million shsAverage Volume2.79 million shsMarket Capitalization$443.73 millionP/E RatioN/ADividend YieldN/APrice Target$6.00Consensus RatingModerate Buy Company Overview Evolent Health, Inc. is a U.S.-based healthcare technology and services company that partners with health systems, physician organizations and health plans to design, build and operate value-based care programs. Headquartered in Arlington, Virginia, the company was founded in 2011 as a joint venture between TPG and the University of Pittsburgh Medical Center (UPMC). Evolent Health aims to help its clients transition from fee-for-service payment models to value-based care arrangements by leveraging its proprietary technology platforms and clinical expertise. The company’s core offerings include care management solutions, population health analytics and clinical advisory services. Evolent Health’s technology platform integrates claims and clinical data to support risk stratification, predictive modeling and performance reporting. Through its Care Management and Evolent Clinical services, the company deploys teams of nurses, care managers and data analysts to work directly with participating providers and patients, focusing on chronic disease management, preventive care outreach and utilization management. Evolent Health serves a broad range of geographies across the United States, with key clients spanning commercial, Medicare Advantage and Medicaid populations. The company has collaborated with regional health systems and national insurers to launch accountable care organizations (ACOs), bundled payment programs and total cost-of-care arrangements. By aligning incentives and sharing financial risk, Evolent Health’s partnerships aim to improve patient outcomes while controlling healthcare spending. Leadership at Evolent Health is headed by Chief Executive Officer Frank Williams, who brings extensive experience in healthcare finance and operations. The management team includes industry veterans in clinical services, technology development and regulatory affairs, reflecting the company’s integrated approach to supporting its clients’ value-based care initiatives.AI Generated. May Contain Errors. Read More Evolent Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks47th Percentile Overall ScoreEVH MarketRank™: Evolent Health scored higher than 47% of companies evaluated by MarketBeat, and ranked 428th out of 624 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingEvolent Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.71, and is based on no strong buy ratings, 13 buy ratings, 3 hold ratings, and 1 sell rating.Upside PotentialEvolent Health has a consensus price target of $6.00, representing about 52.1% upside from its current price of $3.95.Amount of Analyst CoverageEvolent Health has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Evolent Health's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Evolent Health are expected to grow in the coming year, from ($0.23) to $0.03 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Evolent Health is -0.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Evolent Health is -0.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEvolent Health has a P/B Ratio of 1.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Evolent Health's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted13.99% of the float of Evolent Health has been sold short.Short Interest Ratio / Days to CoverEvolent Health has a short interest ratio ("days to cover") of 6.21.Change versus previous monthShort interest in Evolent Health has recently decreased by 4.97%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEvolent Health does not currently pay a dividend.Dividend GrowthEvolent Health does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Evolent Health this week, compared to 3 articles on an average week.Search InterestOnly 8 people have searched for EVH on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.MarketBeat Follows2 people have added Evolent Health to their MarketBeat watchlist in the last 30 days. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Evolent Health insiders have not sold or bought any company stock.Percentage Held by Insiders1.48% of the stock of Evolent Health is held by insiders.Percentage Held by InstitutionsEvolent Health has minimal institutional ownership at this time.Read more about Evolent Health's insider trading history. Receive EVH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EVH Stock News HeadlinesAgentic AI Powers U.S. Healthcare StocksMay 17, 2026 | 247wallst.comEvolent Health, Inc. (EVH) Q1 2026 Earnings Call TranscriptMay 8, 2026 | seekingalpha.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.May 24 at 1:00 AM | Profits Run (Ad)Evolent (EVH) Q1 2026 Earnings Call TranscriptMay 8, 2026 | finance.yahoo.comWhy is Evolent Health (EVH) stock soaring todayMay 8, 2026 | msn.comEvolent Health (NYSE:EVH) Misses Q1 CY2026 Revenue Estimates, But Stock Soars 5.1%May 7, 2026 | finance.yahoo.comEvolent Announces First Quarter 2026 ResultsMay 7, 2026 | prnewswire.comEvolent Health (EVH) reports Q1: Everything you need to know ahead of earningsMay 6, 2026 | msn.comSee More Headlines EVH Stock Analysis - Frequently Asked Questions How have EVH shares performed this year? Evolent Health's stock was trading at $4.00 at the beginning of the year. Since then, EVH stock has decreased by 1.4% and is now trading at $3.9450. How were Evolent Health's earnings last quarter? Evolent Health, Inc (NYSE:EVH) released its quarterly earnings data on Thursday, May, 7th. The technology company reported ($0.02) earnings per share for the quarter, beating the consensus estimate of ($0.05) by $0.03. Evolent Health's revenue was up 2.6% on a year-over-year basis. Read the conference call transcript. When did Evolent Health IPO? Evolent Health (EVH) raised $172 million in an initial public offering (IPO) on Friday, June 5th 2015. The company issued 11,500,000 shares at $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers. Who are Evolent Health's major shareholders? Evolent Health's top institutional shareholders include Maverick Capital Ltd. (2.29%), Dimensional Fund Advisors LP (1.60%), Bank of New York Mellon Corp (0.29%) and Sei Investments Co. (0.27%). Insiders that own company stock include Frank J Williams, Seth Blackley, Daniel Joseph Mccarthy, John Paul Johnson, Jonathan Weinberg, Diane Holder, Emily Ann Rafferty, Brendan B Springstubb and Cheryl Scott. View institutional ownership trends. How do I buy shares of Evolent Health? Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Evolent Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Evolent Health investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH) and Southern First Bancshares (SFST). Company Calendar Last Earnings5/07/2026Today5/24/2026Next Earnings (Estimated)8/06/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3w+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 For the last 3 weeks, EVH's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorComputer and Technology Industry INTERNET SOFTWARE Sub-IndustryBusiness Services Current SymbolNYSE:EVH CIK1628908 Webwww.evolenthealth.com Phone(571) 389-6000Fax571-389-6001Employees4,200Year Founded2011Price Target and Rating Average Price Target for Evolent Health$6.00 High Price Target$10.00 Low Price Target$3.00 Potential Upside/Downside+52.1%Consensus RatingModerate Buy Rating Score (0-4)2.71 Research Coverage17 Analysts Profitability EPS (Trailing Twelve Months)($4.76) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$534.51 million Net Margins-26.29% Pretax Margin-26.32% Return on Equity0.36% Return on Assets0.10% Debt Debt-to-Equity Ratio2.46 Current Ratio1.32 Quick Ratio1.32 Sales & Book Value Annual Sales$1.88 billion Price / Sales0.24 Cash Flow$4.70 per share Price / Cash Flow0.84 Book Value$3.52 per share Price / Book1.12Miscellaneous Outstanding Shares112,480,000Free Float110,816,000Market Cap$443.73 million OptionableOptionable Beta0.83 Social Links 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NYSE:EVH) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredYour computer is about to become a museum pieceFuturist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredMusk's shopping list: batteries ✓ solar ✓ data ✓ power ___Elon Musk has a clear pattern: when a supplier becomes mission-critical, he acquires it. He bought SolarCity f...Behind the Markets | SponsoredThis small stock could surge when SpaceX goes publicWhen SpaceX goes public, billions in capital won't just flow into one stock - it will flood the entire sector....NXT Wave Research | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolent Health, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Evolent Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
